Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Rang in aandelen
#4334
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Aandeelprijs
$3.87
Marktkapitalisatie
$3.57B
Verandering (1 dag)
-1.64%
Verandering (1 jaar)
9.08%
Land
CN
Handel Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Categorie
Healthcare
Aantal uitstaande aandelen voor Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Aantal uitstaande aandelen per October 2026: 0
Volgens de laatste financiële rapporten en de aandelenkoers van Hubei Jumpcan Pharmaceutical Co., Ltd. bedraagt het huidige aantal uitstaande aandelen 0. Aan het einde van October 2026 had het bedrijf 0 uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) van 2001 tot 2026
Uitstaande aandelen aan het einde van elk jaar
| Jaar | Uitstaande aandelen | Wijzigen |
|---|---|---|
| 2025 | 921.17M | 0.43% |
| 2024 | 917.23M | 0.08% |
| 2023 | 916.49M | 3.02% |
| 2022 | 889.65M | 0.16% |
| 2021 | 888.27M | 6.41% |
| 2020 | 834.78M | 2.44% |
| 2019 | 814.92M | 0.43% |
| 2018 | 811.47M | 0.23% |
| 2017 | 809.62M | 1.40% |
| 2016 | 798.45M | 2.34% |
| 2015 | 780.19M | 0.64% |
| 2014 | 775.21M | 27.04% |
| 2013 | 610.19M | 0.13% |
| 2012 | 609.41M | 341.10% |
| 2011 | 138.16M | -0.09% |
| 2010 | 138.28M | 30.05% |
| 2009 | 106.32M | -23.09% |
| 2008 | 138.24M | 0.03% |
| 2007 | 138.21M | 0.12% |
| 2006 | 138.05M | 0.00% |
| 2005 | 138.05M | 0.00% |
| 2004 | 138.05M | 0.00% |
| 2003 | 138.05M | 0.00% |
| 2002 | 138.05M | 0.00% |
| 2001 | 138.05M | 0.00% |
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Uitstaande aandelen | Verschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
